Purchase of Formulation development and GMP manufacture of tablets for early clinical development
Buyer
NameDanmarks Tekniske Universitet - DTU
CountryDK
Published2026-05-06
Deadline—
Value
Estimated—
Awarded€185,530 · 185,530 EUR
WinnerPorton Pharmaceutical Chemicals GmbH
CPV codes
73110000 Research & development servicesDescription
DTU intends to purchase Formulation development and GMP manufacture of tablets for early clinical development from Porton Pharmaceutical Chemicals GmbH. The acquisition concerns specialized pharmaceutical development and manufacturing services required to enable a first-in-human clinical study within the Microbiome Health Initiative (MHI). The services include formulation development, analytical method development and validation, non-GMP and GMP manufacture of an oral solid dosage form (tablets), stability studies, and preparation of documentation to support regulatory submissions (IND/IMPD). The work covers the full IND-enabling drug product package for a novel small-molecule compound within the bile acid class, intended for use in a Phase I human intervention study. The services are highly specialized, research- and development-driven, and closely linked to the specific and regulatory requirements of the project.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-11 | Gas controlled biofoundry for DTU | Danmarks Tekniske Universitet - DTU DK | 86% |
| 2026-05-07 | Twin-screw extruder | Syddansk Universitet DK | 86% |
| 2026-06-16 | Instrument for automated production of blood components. | SYKEHUSINNKJØP HF NO | 86% |
| 2026-05-11 | Provision of Integrated Design Team Services (Lot 1) for Development of a New "One Health" Building on behalf of South East Technological University | South East Technological University (SETU) IE | 86% |
| 2026-05-12 | Plasma enhanced chemical vapour deposition tool | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY FI | 86% |
| 2026-06-02 | Intention notice: 9393 Automatic HIV analyser - the Life Science Building | SYKEHUSINNKJØP HF NO | 85% |